Anavex Life Sciences Corp.

NasdaqGS:AVXL Stock Report

Mkt Cap: US$916.1m

Anavex Life Sciences Company Information

Anavex Life Sciences Corp.'s employee growth, exchange listings and data sources


Key Information

  • Name: Anavex Life Sciences Corp.
  • Ticker: AVXL
  • Exchange: NasdaqGS
  • Founded: 2004
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Implied Market Cap: US$916.051m
  • Shares outstanding: 77.96m
  • Website: https://www.anavex.com

Number of Employees


Location

  • Anavex Life Sciences Corp.
  • 630 5th Avenue
  • 20th Floor
  • New York
  • New York
  • 10111
  • United States


Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
AVXLNasdaqGS (Nasdaq Global Select)YesCommon SharesUSUSDApr 2006
12X1DB (Deutsche Boerse AG)YesCommon SharesDEEURApr 2006
0HFRLSE (London Stock Exchange)YesCommon SharesGBUSDApr 2006

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2023/02/08 00:00
End of Day Share Price2023/02/07 00:00
Earnings2022/09/30
Annual Earnings2022/09/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.